Newswise — LOS ANGELES (August 12, 2024) – Children’s Hospital Los Angeles has named James F. Amatruda, MD, PhD, a highly respected medical leader, clinician, and researcher with global recognitions, as Director of the Cancer and Blood Disease Institute (CBDI) and Chief of the Division of Hematology-Oncology at Children’s Hospital Los Angeles (CHLA). He had been serving in these roles on an interim basis since September 2023.
He is also the new Alfred E. Mann Family Foundation Chair in Cancer Research. “We are thrilled to welcome Dr.
Amatruda as the new Director of the Cancer and Blood Disease Institute and Chief of the Division of Hematology-Oncology at CHLA,” says Dr. Alan S. Wayne, Pediatrician-in-Chief and Senior Vice President of Academic Affairs at CHLA and Pasadena Guild Chair.
Dr. Wayne is also Chair of the Department of Pediatrics at the Keck School of Medicine of USC. “Dr.
Amatruda’s research and clinical work have established him as an internationally renowned expert in the field of pediatric cancer. Dr. Amatruda’s leadership will further cement CHLA’s standing as one of the leading pediatric cancer and blood disease programs in the nation, and advance research in the development of safer and more effective therapies for children with cancer.
” As CBDI Director and Division Chief, Dr. Amatruda is leading the clinical care, research and education programs in pediatric hematology, oncology, and hematopoietic stem cell transplantation/cellular the.